» Articles » PMID: 7524558

Identification of Myelin-associated Glycoprotein As a Major Myelin-derived Inhibitor of Neurite Growth

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 1994 Oct 1
PMID 7524558
Citations 338
Authors
Affiliations
Soon will be listed here.
Abstract

Contact-dependent axon growth inhibitory activity is present in CNS myelin, but the inhibitory proteins have not been fully characterized. We report here that at least two peaks of inhibitory activity can be separated by fractionating solubilized CNS myelin proteins by DEAE chromatography. A major peak of inhibitory activity corresponded to the elution profile of myelin-associated glycoprotein (MAG). Immunodepletion of MAG from these inhibitory fractions removed neurite growth inhibition, whereas recombinant MAG (ectodomain) was a potent inhibitor of neurite outgrowth. Immunodepletion of MAG from total extracts of CNS myelin restored neurite growth up to 63% of control levels. These results establish that MAG is a significant, and possibly the major, inhibitor in CNS myelin; this has broad implications for axonal regeneration in the injured mammalian CNS.

Citing Articles

Individual Variability in the Structural Connectivity Architecture of the Human Brain.

Huang W, Chen H, Liu Z, Dong X, Feng G, Liu G J Neurosci. 2024; 45(5).

PMID: 39667899 PMC: 11780350. DOI: 10.1523/JNEUROSCI.2139-23.2024.


A review focuses on a neglected and controversial component of SCI: myelin debris.

Zhou Y, Xu T, Zhou Y, Han W, Wu Z, Yang C Front Immunol. 2024; 15():1436031.

PMID: 39650659 PMC: 11621000. DOI: 10.3389/fimmu.2024.1436031.


Glial cell derived pathway directs regenerating optic nerve axons toward the CNS midline.

Harvey B, Baxter M, Garcia A, Granato M bioRxiv. 2024; .

PMID: 39464127 PMC: 11507804. DOI: 10.1101/2024.10.15.618346.


Axonal Regeneration after Spinal Cord Injury: Molecular Mechanisms, Regulatory Pathways, and Novel Strategies.

Elmalky M, Alvarez-Bolado G, Younsi A, Skutella T Biology (Basel). 2024; 13(9).

PMID: 39336130 PMC: 11428726. DOI: 10.3390/biology13090703.


Pharmacological intervention for chronic phase of spinal cord injury.

Tohda C Neural Regen Res. 2024; 20(5):1377-1389.

PMID: 38934397 PMC: 11624870. DOI: 10.4103/NRR.NRR-D-24-00176.